Pregabalin (lyrica) in the treatment of essential tremor
Identifieur interne : 001819 ( PascalFrancis/Corpus ); précédent : 001818; suivant : 001820Pregabalin (lyrica) in the treatment of essential tremor
Auteurs : Theresa A. Zesiewicz ; Christopher L. Ward ; Robert A. Hauser ; Jessica A. Pease Campbell ; Kelly L. SullivanSource :
- Movement disorders [ 0885-3185 ] ; 2007.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
We report on 2 essential tremor patients who experienced marked improvement in upper extremity tremor with the use of pregabalin (Lyrica, PGB). On PGB 200 mg/day, tremor amplitude was reduced by at least 40% in the worst affected hand in both patients as measured by accelerometry. Both patients also reported moderate reduction in tremor on the Clinical Global Impression Scale, and Fahn-Tolosa-Marin Part I scores were markedly improved.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 07-0133233 INIST |
---|---|
ET : | Pregabalin (lyrica) in the treatment of essential tremor |
AU : | ZESIEWICZ (Theresa A.); WARD (Christopher L.); HAUSER (Robert A.); PEASE CAMPBELL (Jessica A.); SULLIVAN (Kelly L.) |
AF : | Parkinson 's Disease and Movement Disorders Center, Department of Neurology, University of South Florida/Tampa, Florida/Etats-Unis; Department of Molecular Therapeutics, Neuroscience Program, University of South Florida/Tampa, Florida/Etats-Unis; National Parkinson's Foundation Center of Excellence, Department of Psychiatry, University of South Florida/Tampa, Florida/Etats-Unis |
DT : | Publication en série; Courte communication, note brève; Niveau analytique |
SO : | Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2007; Vol. 22; No. 1; Pp. 139-141; Bibl. 12 ref. |
LA : | Anglais |
EA : | We report on 2 essential tremor patients who experienced marked improvement in upper extremity tremor with the use of pregabalin (Lyrica, PGB). On PGB 200 mg/day, tremor amplitude was reduced by at least 40% in the worst affected hand in both patients as measured by accelerometry. Both patients also reported moderate reduction in tremor on the Clinical Global Impression Scale, and Fahn-Tolosa-Marin Part I scores were markedly improved. |
CC : | 002B17; 002B17A01; 002B02Q; 002B02B11 |
FD : | Système nerveux pathologie; Tremblement; Prégabaline; Traitement |
FG : | Mouvement involontaire; Trouble neurologique |
ED : | Nervous system diseases; Tremor; Pregabalin; Treatment |
EG : | Involuntary movement; Neurological disorder |
SD : | Sistema nervioso patología; Temblor; Pregabalina; Tratamiento |
LO : | INIST-20953.354000145483830240 |
ID : | 07-0133233 |
Links to Exploration step
Pascal:07-0133233Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Pregabalin (lyrica) in the treatment of essential tremor</title>
<author><name sortKey="Zesiewicz, Theresa A" sort="Zesiewicz, Theresa A" uniqKey="Zesiewicz T" first="Theresa A." last="Zesiewicz">Theresa A. Zesiewicz</name>
<affiliation><inist:fA14 i1="01"><s1>Parkinson 's Disease and Movement Disorders Center, Department of Neurology, University of South Florida</s1>
<s2>Tampa, Florida</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Department of Molecular Therapeutics, Neuroscience Program, University of South Florida</s1>
<s2>Tampa, Florida</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>National Parkinson's Foundation Center of Excellence, Department of Psychiatry, University of South Florida</s1>
<s2>Tampa, Florida</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ward, Christopher L" sort="Ward, Christopher L" uniqKey="Ward C" first="Christopher L." last="Ward">Christopher L. Ward</name>
</author>
<author><name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A." last="Hauser">Robert A. Hauser</name>
</author>
<author><name sortKey="Pease Campbell, Jessica A" sort="Pease Campbell, Jessica A" uniqKey="Pease Campbell J" first="Jessica A." last="Pease Campbell">Jessica A. Pease Campbell</name>
</author>
<author><name sortKey="Sullivan, Kelly L" sort="Sullivan, Kelly L" uniqKey="Sullivan K" first="Kelly L." last="Sullivan">Kelly L. Sullivan</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">07-0133233</idno>
<date when="2007">2007</date>
<idno type="stanalyst">PASCAL 07-0133233 INIST</idno>
<idno type="RBID">Pascal:07-0133233</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001819</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Pregabalin (lyrica) in the treatment of essential tremor</title>
<author><name sortKey="Zesiewicz, Theresa A" sort="Zesiewicz, Theresa A" uniqKey="Zesiewicz T" first="Theresa A." last="Zesiewicz">Theresa A. Zesiewicz</name>
<affiliation><inist:fA14 i1="01"><s1>Parkinson 's Disease and Movement Disorders Center, Department of Neurology, University of South Florida</s1>
<s2>Tampa, Florida</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Department of Molecular Therapeutics, Neuroscience Program, University of South Florida</s1>
<s2>Tampa, Florida</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>National Parkinson's Foundation Center of Excellence, Department of Psychiatry, University of South Florida</s1>
<s2>Tampa, Florida</s2>
<s3>USA</s3>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ward, Christopher L" sort="Ward, Christopher L" uniqKey="Ward C" first="Christopher L." last="Ward">Christopher L. Ward</name>
</author>
<author><name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A." last="Hauser">Robert A. Hauser</name>
</author>
<author><name sortKey="Pease Campbell, Jessica A" sort="Pease Campbell, Jessica A" uniqKey="Pease Campbell J" first="Jessica A." last="Pease Campbell">Jessica A. Pease Campbell</name>
</author>
<author><name sortKey="Sullivan, Kelly L" sort="Sullivan, Kelly L" uniqKey="Sullivan K" first="Kelly L." last="Sullivan">Kelly L. Sullivan</name>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2007">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Nervous system diseases</term>
<term>Pregabalin</term>
<term>Treatment</term>
<term>Tremor</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term>
<term>Tremblement</term>
<term>Prégabaline</term>
<term>Traitement</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We report on 2 essential tremor patients who experienced marked improvement in upper extremity tremor with the use of pregabalin (Lyrica, PGB). On PGB 200 mg/day, tremor amplitude was reduced by at least 40% in the worst affected hand in both patients as measured by accelerometry. Both patients also reported moderate reduction in tremor on the Clinical Global Impression Scale, and Fahn-Tolosa-Marin Part I scores were markedly improved.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>22</s2>
</fA05>
<fA06><s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Pregabalin (lyrica) in the treatment of essential tremor</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>ZESIEWICZ (Theresa A.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>WARD (Christopher L.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>HAUSER (Robert A.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>PEASE CAMPBELL (Jessica A.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>SULLIVAN (Kelly L.)</s1>
</fA11>
<fA14 i1="01"><s1>Parkinson 's Disease and Movement Disorders Center, Department of Neurology, University of South Florida</s1>
<s2>Tampa, Florida</s2>
<s3>USA</s3>
</fA14>
<fA14 i1="02"><s1>Department of Molecular Therapeutics, Neuroscience Program, University of South Florida</s1>
<s2>Tampa, Florida</s2>
<s3>USA</s3>
</fA14>
<fA14 i1="03"><s1>National Parkinson's Foundation Center of Excellence, Department of Psychiatry, University of South Florida</s1>
<s2>Tampa, Florida</s2>
<s3>USA</s3>
</fA14>
<fA20><s1>139-141</s1>
</fA20>
<fA21><s1>2007</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000145483830240</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2007 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>12 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>07-0133233</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>We report on 2 essential tremor patients who experienced marked improvement in upper extremity tremor with the use of pregabalin (Lyrica, PGB). On PGB 200 mg/day, tremor amplitude was reduced by at least 40% in the worst affected hand in both patients as measured by accelerometry. Both patients also reported moderate reduction in tremor on the Clinical Global Impression Scale, and Fahn-Tolosa-Marin Part I scores were markedly improved.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17A01</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B02Q</s0>
</fC02>
<fC02 i1="04" i2="X"><s0>002B02B11</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Tremblement</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Tremor</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Temblor</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Prégabaline</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Pregabalin</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Pregabalina</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Traitement</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Treatment</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>10</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Mouvement involontaire</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Involuntary movement</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Movimiento involuntario</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Trouble neurologique</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Neurological disorder</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Trastorno neurológico</s0>
<s5>38</s5>
</fC07>
<fN21><s1>085</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 07-0133233 INIST</NO>
<ET>Pregabalin (lyrica) in the treatment of essential tremor</ET>
<AU>ZESIEWICZ (Theresa A.); WARD (Christopher L.); HAUSER (Robert A.); PEASE CAMPBELL (Jessica A.); SULLIVAN (Kelly L.)</AU>
<AF>Parkinson 's Disease and Movement Disorders Center, Department of Neurology, University of South Florida/Tampa, Florida/Etats-Unis; Department of Molecular Therapeutics, Neuroscience Program, University of South Florida/Tampa, Florida/Etats-Unis; National Parkinson's Foundation Center of Excellence, Department of Psychiatry, University of South Florida/Tampa, Florida/Etats-Unis</AF>
<DT>Publication en série; Courte communication, note brève; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2007; Vol. 22; No. 1; Pp. 139-141; Bibl. 12 ref.</SO>
<LA>Anglais</LA>
<EA>We report on 2 essential tremor patients who experienced marked improvement in upper extremity tremor with the use of pregabalin (Lyrica, PGB). On PGB 200 mg/day, tremor amplitude was reduced by at least 40% in the worst affected hand in both patients as measured by accelerometry. Both patients also reported moderate reduction in tremor on the Clinical Global Impression Scale, and Fahn-Tolosa-Marin Part I scores were markedly improved.</EA>
<CC>002B17; 002B17A01; 002B02Q; 002B02B11</CC>
<FD>Système nerveux pathologie; Tremblement; Prégabaline; Traitement</FD>
<FG>Mouvement involontaire; Trouble neurologique</FG>
<ED>Nervous system diseases; Tremor; Pregabalin; Treatment</ED>
<EG>Involuntary movement; Neurological disorder</EG>
<SD>Sistema nervioso patología; Temblor; Pregabalina; Tratamiento</SD>
<LO>INIST-20953.354000145483830240</LO>
<ID>07-0133233</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001819 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001819 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:07-0133233 |texte= Pregabalin (lyrica) in the treatment of essential tremor }}
This area was generated with Dilib version V0.6.23. |